Back to Awarded Treatment Trials


Awarded Trial: 05T-656

Grant ID

05T-656

Illness

BP Depression

Primary Drug/Intervention

Magnetic Seizure Therapy (MST)

Primary Dosage

N/A

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Compelted

Investigator

Lisanby

Sample Size

75

Duration of Study Period for Each Subject

32 weeks

Outcome Measurements

HRSD, IDS-C, IDS-SR, GAF, CGI-I, YMRS, Columbia Univ. ECT side Effects Scale

Results

N/A

Publication

N/A

Link

N/A

PI Name

Sarah Lisanby

Degree

MD

Center

Research Foundation for Mental Hygiene, Inc.

Institution

New York Psychiatric Institute Division

Address

1051 Riverside Drive, Unit #126

City or Town

New York

State or Province

NY

Zip or Postal Code

10032

Country

USA

Email Address

slisanby@columbia.edu